
David H. Vesole, MD, PhD, discusses the importance of developing off-the-shelf CAR T-cell therapy products in multiple myeloma.
David H. Vesole, MD, PhD, discusses the importance of developing off-the-shelf CAR T-cell therapy products in multiple myeloma.
David H. Vesole, MD, PhD, discusses the advantages of CAR T-cell therapy in multiple myeloma.
Published: October 5th 2020 | Updated:
Published: October 9th 2020 | Updated: